BeStock  
Stocks › Biotechnology › ALNY

Alnylam Pharmaceuticals ALNY

US equityMarket cap rank #931Biotechnology
$143.82 −$4.00 (-2.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $144.50 +0.47%
Open$148.35
Prev close$147.82
Day range$143.40 – $151.41
Volume2.33M
Market cap$19.26B
P/E (TTM)7.5
Dividend yield–

Analyst view

ConsensusBuy
Analysts25
Average target$297.59+106.9% vs. price
  • Buy 76%
  • Hold 24%
Low $199.00Now $143.82Avg $297.59High $410.00

Recent rating changes

The last 20 actions on file set price targets from $199.00 to $455.00, averaging $312.42.

DateFirmRatingTarget
20 Nov 2026 BMO Capital BUY $293.00
18 Nov 2026 J.P. Morgan BUY $254.00
17 Nov 2026 Cantor Fitzgerald HOLD $205.00
17 Nov 2026 H.C. Wainwright BUY $250.00
11 Nov 2026 H.C. Wainwright BUY $455.00
10 Nov 2026 Piper Sandler BUY $410.00
10 Nov 2026 Citi BUY $250.00
9 Nov 2026 Citi BUY $250.00
6 Nov 2026 Cantor Fitzgerald HOLD $290.00
6 Nov 2026 H.C. Wainwright BUY $455.00
5 Nov 2026 Piper Sandler BUY $410.00
5 Nov 2026 BofA Securities BUY –
5 Nov 2026 BMO Capital BUY $292.00
5 Nov 2026 H.C. Wainwright BUY $455.00
5 Nov 2026 Oppenheimer BUY $320.00
4 Nov 2026 Wells Fargo HOLD $220.00
2 Nov 2026 CCORF BUY $323.00
2 Nov 2026 Truist Financial HOLD $225.00
2 Nov 2026 Barclays BUY $380.00
30 Oct 2026 Bernstein HOLD $199.00

Discussion

No comments yet — be the first to weigh in on ALNY.

Sign in to join the discussion.

Scroll to Top